Prior authorization, a longtime bane of providers, is on track to become less burdensome thanks to a new Centers for Medicare & Medicaid Services (CMS) proposed rule. The good news is the rule includes Medicare Advantage, which was left out of a previous version. But results, already delayed once, may still come slowly.

On December 6th, CMS announced a proposed rule, “Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations,” which replaces the previous CMS rule from 2020. Some key aspects of the rule include: increased transparency into prior authorization decisions; quicker turnaround times for said decisions; and automating certain processes that remain heavily manual to this day. 

Cohere Health’s Alina M. Czekai, Vice President of Strategic Partnerships & former Senior Advisor to CMS Administrator Seema Verma, who worked on the original rule, sat down with Roy Edroso, Editor, Part B News, to discuss how this new initiative would improve transparency within the prior authorization process, reduce physician burden, and result in faster access to patient care.

Published On: December 19th, 2022Categories: Compliance 201, News

Share:

About the Author: Cohere Health

Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient's entire care journey. Cohere's intelligent prior authorization solutions reduce administrative expenses while improving patient outcomes. The company is a Top 5 LinkedIn™ Startup, winner of the TripleTree iAward, consecutive KLAS Research’s Points of Light recipient, and has been named to both Fierce Healthcare's Fierce 15 and CB Insights' Digital Health 150 lists. Cohere's investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.